← Back
Data updated: Mar 10, 2026
ZHUHAI
OncologyOphthalmologyGastroenterology
ZHUHAI is a pharmaceutical company focused on Oncology, Ophthalmology, Gastroenterology. Key products include BEIZRAY.
2024
Since
1
Drugs
-
Trials
2
Approved (2yr)
Recent Activity
SEC Filings
Pro
Loading...
Therapeutic Focus
Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5
Oncology 31%
1 drugs Phase 1: 5
Ophthalmology 26%
0 drugs Phase 3: 1 Phase 2: 2 Phase 1: 1
Gastroenterology 23%
1 drugs Phase 2: 1
Infectious Disease 20%
0 drugs Phase 3: 1 Phase 2: 1 Phase 1: 1
Pipeline Strength Pro
Loading...
Competitors Pro
Pfizer big-pharma
Oncology, Infectious Disease, Gastroenterology
Baxter specialty
Infectious Disease, Oncology, Ophthalmology
AbbVie big-pharma
Oncology, Infectious Disease, Ophthalmology
Bristol-Myers Squibb big-pharma
Oncology, Gastroenterology, Infectious Disease
FOUGERA PHARMS other
Ophthalmology, Infectious Disease, Oncology
Active (1)
Discontinued (0)
Company Info
- First Approval
- 2024-10-23
- Latest
- 2025-04-22
- Applications
- 1